Characteristics | BTNL9 expression | p value | |
---|---|---|---|
Low (n = 251) | High (n = 251) | ||
Age, n (%) | Â | Â | 1.000 |
≤ 45 | 118 (23.5%) | 118 (23.5%) |  |
> 45 | 133 (26.5%) | 133 (26.5%) |  |
Gender, n (%) | Â | Â | 0.687 |
Female | 186 (37.1%) | 181 (36.1%) | Â |
Male | 65 (12.9%) | 70 (13.9%) | Â |
Race, n (%) | Â | Â | 0.341 |
Asian | 26 (6.3%) | 25 (6.1%) | Â |
Black or African American | 18 (4.4%) | 9 (2.2%) | Â |
White | 174 (42.4%) | 158 (38.5%) | Â |
T stage, n (%) |  |  | < 0.001 |
T1 | 62 (12.4%) | 81 (16.2%) | Â |
T2 | 67 (13.4%) | 97 (19.4%) | Â |
T3 | 102 (20.4%) | 68 (13.6%) | Â |
T4 | 20 (4%) | 3 (0.6%) | Â |
N stage, n (%) |  |  | < 0.001 |
N0 | 96 (21.2%) | 133 (29.4%) | Â |
N1 | 134 (29.6%) | 89 (19.7%) | Â |
M stage, n (%) | Â | Â | 0.183 |
M0 | 149 (51.2%) | 133 (45.7%) | Â |
M1 | 7 (2.4%) | 2 (0.7%) | Â |
Pathologic stage, n (%) |  |  | < 0.001 |
Stage I | 132 (26.4%) | 149 (29.8%) | Â |
Stage II | 12 (2.4%) | 40 (8%) | Â |
Stage III | 70 (14%) | 42 (8.4%) | Â |
Stage IV | 36 (7.2%) | 19 (3.8%) | Â |
Histological type, n (%) |  |  | < 0.001 |
Classical | 198 (39.4%) | 158 (31.5%) | Â |
Follicular | 20 (4%) | 81 (16.1%) | Â |
Other | 2 (0.4%) | 7 (1.4%) | Â |
Tall Cell | 31 (6.2%) | 5 (1%) | Â |
Residual tumor, n (%) | Â | Â | 0.014 |
R0 | 185 (42%) | 199 (45.2%) | Â |
R1 | 35 (8%) | 17 (3.9%) | Â |
R2 | 3 (0.7%) | 1 (0.2%) | Â |
Extrathyroidal extension, n (%) |  |  | < 0.001 |
No | 138 (28.5%) | 193 (39.9%) | Â |
Yes | 105 (21.7%) | 48 (9.9%) | Â |
Primary neoplasm focus type, n (%) | Â | Â | 0.015 |
Multifocal | 100 (20.3%) | 126 (25.6%) | Â |
Unifocal | 148 (30.1%) | 118 (24%) | Â |
Neoplasm location, n (%) | Â | Â | 0.843 |
Bilateral | 40 (8.1%) | 46 (9.3%) | Â |
Isthmus | 12 (2.4%) | 10 (2%) | Â |
Left lobe | 85 (17.1%) | 90 (18.1%) | Â |
Right lobe | 109 (22%) | 104 (21%) | Â |
Thyroid gland disorder history, n (%) | Â | Â | 0.038 |
Lymphocytic Thyroiditis | 37 (8.3%) | 34 (7.7%) | Â |
Nodular Hyperplasia | 23 (5.2%) | 45 (10.1%) | Â |
Normal | 149 (33.6%) | 131 (29.5%) | Â |
Other, specify | 12 (2.7%) | 13 (2.9%) | Â |
Living status, n (%) | Â | Â | 0.799 |
Alive | 242 (48.2%) | 244 (48.6%) | Â |
Dead | 9 (1.8%) | 7 (1.4%) | Â |
Age, median (IQR) | 46 (35, 58) | 46 (35, 57) | 0.680 |